Ten-year experience with arterial embolization for peptic ulcer bleeding: N-butyl cyanoacrylate glue versus other embolic agents.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
May 2021
Historique:
received: 08 04 2020
accepted: 14 10 2020
revised: 01 09 2020
pubmed: 1 11 2020
medline: 16 4 2021
entrez: 31 10 2020
Statut: ppublish

Résumé

To compare our experience with N-butyl cyanoacrylate glue as the primary embolic agent versus other embolic agents for transcatheter arterial embolization (TAE) in refractory peptic ulcer bleeding and to identify factors associated with early rebleeding and 30-day mortality. Retrospective study of 148 consecutive patients comparing the clinical success rate in 78 patients managed with Glubran®2 N-butyl cyanoacrylate metacryloxysulfolane (NBCA-MS) alone or with other agents and 70 with other embolic agents only (coils, microspheres, ethylene-vinyl alcohol copolymer, or gelatin sponge) at a university center in 2008-2019. Univariate and multivariate logistic regression analyses were done to identify prognostic factors. The technical success rate was 95.3% and the primary clinical success was 64.5%. The early rebleeding and day-30 mortality rates were 35.4% and 21.3%, respectively. Rebleeding was significantly less common with than without Glubran®2 (OR, 0.47; 95% CI, 0.22-0.99; p = .047) and significantly more common with coils used alone (OR, 20.4; 95% CI, 10.13-50.14; p = .024). The only other factor independently associated with early rebleeding was having two or more comorbidities (OR, 20.14; 95% CI, 10.01-40.52; p = .047). Day-30 mortality was similar in the two treatment groups. A lower initial hemoglobin level was significantly associated with higher day-30 mortality (OR, 10.38; 95% CI, 10.10-10.74; p = .006). Fluoroscopy time was significantly shorter with Glubran®2 (20.8 ± 11.5 min vs. 35.5 ± 23.4 min, p = .002). Both groups (Glubran®2 vs. other agents) had similar rates of overall complications (10.7% vs. 9.1%, respectively, p = .786). Glubran®2 NBCA-MS as the primary agent allowed for faster and better clinical success compared to other embolic agents when used for TAE to safely stop refractory peptic ulcer bleeding. • Choice of embolic agent for arterial embolization of refractory peptic ulcer bleeding is still debated. We compared our experience with N-butyl cyanoacrylate (NBCA) glue vs. other embolic agents. • The use of Glubran®2 NBCA glue in the endovascular management of refractory peptic ulcer bleeding was significantly faster and more effective, and at least as safe compared to other embolic agents. • NBCA glue offers several advantages compared to other embolic agents and provides rapid hemostasis when used for arterial embolization to treat refractory peptic ulcer bleeding. It should be the first-line therapy.

Identifiants

pubmed: 33128601
doi: 10.1007/s00330-020-07427-y
pii: 10.1007/s00330-020-07427-y
doi:

Substances chimiques

Cyanoacrylates 0
Enbucrilate F8CEP82QNP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3015-3026

Références

Gralnek IM, Dumonceau JM, Kuipers EJ et al (2015) Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 47:a1–a46
doi: 10.1055/s-0034-1393172
Van Leerdam ME (2008) Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol 22:209–224
doi: 10.1016/j.bpg.2007.10.011
Hearnshaw SA, Logan RF, Lowe D, Travis SP, Murphy MF, Palmer KR (2011) Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 60:1327–1335
doi: 10.1136/gut.2010.228437
Chiu PW, Ng EK, Cheung FK et al (2009) Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy. Clin Gastroenterol Hepatol 7:311–316
doi: 10.1016/j.cgh.2008.08.044
Lu Y, Loffroy R, Lau JY, Barkun A (2014) Multidisciplinary management strategies for acute non-variceal upper gastrointestinal bleeding. Br J Surg 101:e34–e50
doi: 10.1002/bjs.9351
Rösch J, Dotter CT, Brown MJ (1972) Selective arterial embolization. A new method for control of acute gastrointestinal bleeding. Radiology 102:303–306
doi: 10.1148/102.2.303
Ripoll C, Bañares R, Beceiro I et al (2004) Comparison of transcatheter arterial embolization and surgery for treatment of bleeding peptic ulcer after endoscopic treatment failure. J Vasc Interv Radiol 15:447–450
doi: 10.1097/01.RVI.0000126813.89981.B6
Beggs AD, Dilworth MP, Powell SL, Atherton H, Griffiths EA (2014) A systematic review of transarterial embolization versus emergency surgery in treatment of major nonvariceal upper gastrointestinal bleeding. Clin Exp Gastroenterol 7:93–104
doi: 10.2147/CEG.S56725
Sverdén E, Mattsson F, Lindström D, Sondén A, Lu Y, Lagergren J (2019) Transcatheter arterial embolization compared with surgery for uncontrolled peptic ulcer bleeding: a population-based cohort study. Ann Surg 269:304–309
doi: 10.1097/SLA.0000000000002565
Kyaw M, Tse Y, Ang D, Ang TL, Lau J (2014) Embolization versus surgery for peptic ulcer bleeding after failed endoscopic hemostasis: a meta-analysis. Endosc Int Open 2:E6–E14
doi: 10.1055/s-0034-1365235
Schenker MP, Duszak R, Soulen MC et al (2001) Upper gastrointestinal hemorrhage and transcatheter embolotherapy: clinical and technical factors impacting success and survival. J Vasc Interv Radiol 12:1263–1271
doi: 10.1016/S1051-0443(07)61549-8
Ang D, Teo EK, Tan A et al (2012) A comparison of surgery versus transcatheter angiographic embolization in the treatment of nonvariceal upper gastrointestinal bleeding uncontrolled by endoscopy. Eur J Gastroenterol Hepatol 24:929–938
doi: 10.1097/MEG.0b013e32835463bc
Abdulmalak G, Chevallier O, Falvo N et al (2018) Safety and efficacy of transcatheter embolization with Glubran®2 cyanoacrylate glue for acute arterial bleeding: a single-center experience with 104 patients. Abdom Radiol (NY) 43:723–733
doi: 10.1007/s00261-017-1267-4
Yonemitsu T, Kawai N, Sato M et al (2009) Evaluation of transcatheter arterial embolization with gelatin sponge particles, microcoils, and n-butyl cyanoacrylate for acute arterial bleeding in a coagulopathic condition. J Vasc Interv Radiol 20:1176–1187
doi: 10.1016/j.jvir.2009.06.005
Kim PH, Tsauo J, Shin JH, Yun SC (2017) Transcatheter arterial embolization of gastrointestinal bleeding with N-butyl cyanoacrylate: a systematic review and meta-analysis of safety and efficacy. J Vasc Interv Radiol 28:522–531
doi: 10.1016/j.jvir.2016.12.1220
Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL (2017) Cirse quality assurance document and standards for classification of complications: the Cirse classification system. Cardiovasc Intervent Radiol 40:1141–1146
doi: 10.1007/s00270-017-1703-4
Stata (2017) Stata Statistical Software: Release 15. StataCorp, LLC, College Station
Mickey RM, Greenland S (1989) The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129:125–137
doi: 10.1093/oxfordjournals.aje.a115101
Forrest JAH, Finlayson NDC, Schearman DJC (1974) Endoscopy of upper gastrointestinal bleeding. Lancet 2:394–397
doi: 10.1016/S0140-6736(74)91770-X
Loffroy R, Guiu B, D’Athis P et al (2009) Arterial embolotherapy for endoscopically unmanageable acute gastroduodenal hemorrhage: predictors of early rebleeding. Clin Gastroenterol Hepatol 7:515–523
doi: 10.1016/j.cgh.2009.02.003
Jae HJ, Chung JW, Jung AY, Lee W, Park JH (2007) Transcatheter arterial embolization of nonvariceal upper gastrointestinal bleeding with N-butyl cyanoacrylate. Korean J Radiol 8:48–56
doi: 10.3348/kjr.2007.8.1.48
Spiliopoulos S, Inchingolo R, Lucatelli P et al (2018) Transcatheter arterial embolization for bleeding peptic ulcers: a multicenter study. Cardiovasc Intervent Radiol 41:1333–1339
doi: 10.1007/s00270-018-1966-4
Loffroy R, Guiu B, Cercueil JP, Krausé D (2009) Endovascular therapeutic embolisation: an overview of occluding agents and their effects on embolised tissues. Curr Vasc Pharmacol 7:250–263
doi: 10.2174/157016109787455617
Toyoda H, Nakano S, Kumada T et al (1996) Estimation of usefulness of N-butyl-2-cyanoacrylate-lipiodol mixture in transcatheter arterial embolization for urgent control of life-threatening massive bleeding from gastric or duodenal ulcer. J Gastroenterol Hepatol 11:252–258
doi: 10.1111/j.1440-1746.1996.tb00071.x
Loffroy R, Rao P, Ota S, De Lin M, Kwak BK, Geschwind JF (2010) Embolization of acute nonvariceal upper gastrointestinal hemorrhage resistant to endoscopic treatment: results and predictors of recurrent bleeding. Cardiovasc Intervent Radiol 33:1088–1100
doi: 10.1007/s00270-010-9829-7
Ichiro I, Shushi H, Akihiko I, Yasuhiko I, Yasuyuki Y (2011) Empiric transcatheter arterial embolization for massive bleeding from duodenal ulcers: efficacy and complications. J Vasc Interv Radiol 22:911–916
doi: 10.1016/j.jvir.2011.03.001
Aina R, Oliva VL, Therasse E et al (2001) Arterial embolotherapy for upper gastrointestinal hemorrhage: outcome assessment. J Vasc Interv Radiol 12:195–200
doi: 10.1016/S1051-0443(07)61825-9
Mille M, Huber J, Wlasak R et al (2015) Prophylactic transcatheter arterial embolization after successful endoscopic hemostasis in the management of bleeding duodenal ulcer. J Clin Gastroenterol 49:738–745
doi: 10.1097/MCG.0000000000000259
Pollak JS, White RI (2001) The use of cyanoacrylate adhesives in peripheral embolization. J Vasc Interv Radiol 12:907–913
doi: 10.1016/S1051-0443(07)61568-1
Takeuchi Y, Morishita H, Sato Y et al (2014) Guidelines for the use of NBCA in vascular embolization devised by the Committee of Practice Guidelines of the Japanese Society of Interventional Radiology (CGJSIR), 2012 edition. Jpn J Radiol 32:500–517
doi: 10.1007/s11604-014-0328-7
Lang EK (1992) Transcatheter embolization in management of hemorrhage from duodenal ulcer: long-term results and complications. Radiology 182:703–707
doi: 10.1148/radiology.182.3.1535883
Huang YS, Chang CC, Liou JM, Jaw FS, Liu KL (2014) Transcatheter arterial embolization with N-butyl cyanoacrylate for nonvariceal upper gastrointestinal bleeding in hemodynamically unstable patients: results and predictors of clinical outcomes. J Vasc Interv Radiol 25:1850–1857
doi: 10.1016/j.jvir.2014.08.005
Hur S, Jae HJ, Lee H, Lee M, Kim HC, Chung JW (2017) Superselective embolization for arterial upper gastrointestinal bleeding using N-butyl cyanoacrylate: a single-center experience in 152 patients. J Vasc Interv Radiol 28:1673–1680
doi: 10.1016/j.jvir.2017.07.027
Lenhart M, Paetzel C, Sackmann M et al (2010) Superselective arterial embolisation with a liquid polyvinyl alcohol copolymer in patients with acute gastrointestinal haemorrhage. Eur Radiol 20:1994–1999
doi: 10.1007/s00330-010-1762-2

Auteurs

Romaric Loffroy (R)

Department of Vascular and Interventional Radiology, François-Mitterrand University Hospital, Dijon, France. romaric.loffroy@chu-dijon.fr.
Department of Vascular and Interventional Radiology, Image-Guided Therapy Center, François-Mitterrand University Hospital, 14 Rue Paul Gaffarel, BP 77908, 21079, Dijon Cedex, France. romaric.loffroy@chu-dijon.fr.

Anne-Solène Desmyttere (AS)

Department of Vascular and Interventional Radiology, François-Mitterrand University Hospital, Dijon, France.

Thomas Mouillot (T)

Department of Gastroenterology and Hepatology, François-Mitterrand University Hospital, Dijon, France.

Julie Pellegrinelli (J)

Department of Vascular and Interventional Radiology, François-Mitterrand University Hospital, Dijon, France.

Olivier Facy (O)

Department of Digestive and Visceral Surgery, François-Mitterrand University Hospital, Dijon, France.

Antoine Drouilllard (A)

Department of Gastroenterology and Hepatology, François-Mitterrand University Hospital, Dijon, France.

Nicolas Falvo (N)

Department of Vascular and Interventional Radiology, François-Mitterrand University Hospital, Dijon, France.

Pierre-Emmanuel Charles (PE)

Department of Anesthesia and Intensive Care, François-Mitterrand University Hospital, Dijon, France.

Marc Bardou (M)

Department of Gastroenterology and Hepatology, François-Mitterrand University Hospital, Dijon, France.

Marco Midulla (M)

Department of Vascular and Interventional Radiology, François-Mitterrand University Hospital, Dijon, France.

Serge Aho-Gléglé (S)

Department of Epidemiology and Biostatistics, François-Mitterrand University Hospital, Dijon, France.

Olivier Chevallier (O)

Department of Vascular and Interventional Radiology, François-Mitterrand University Hospital, Dijon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH